Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

BACKGROUND: The incidence and severity of tuberculosis chemotherapy toxicity is poorly characterised. We used data available from patients in the REMoxTB trial to provide an assessment of the risks associated with the standard regimen and two experimental regimens containing moxifloxacin. METHODS: A...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Infect Dis
Main Authors: Tweed, Conor D., Crook, Angela M., Amukoye, Evans I., Dawson, Rodney, Diacon, Andreas H., Hanekom, Madeline, McHugh, Timothy D., Mendel, Carl M., Meredith, Sarah K., Murphy, Michael E., Murthy, Saraswathi E., Nunn, Andrew J., Phillips, Patrick P. J., Singh, Kasha P., Spigelman, Melvin, Wills, Genevieve H., Gillespie, Stephen H.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6042413/
https://ncbi.nlm.nih.gov/pubmed/29996783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-018-3230-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados